Lantern Pharma raises CSO and CFO salaries and bonus targets effective Jan 1, 2024

Lantern Pharma Inc.

CSO Kishor Bhatia base salary increased to $316,000; target bonus set at 40% of base.
CFO David Margrave base salary increased to $413,800; target bonus set at 40% of base.
Changes effective January 1, 2024, based on independent compensation advisory firm analysis.
Amendments to employment agreements approved by Compensation Committee and Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.